Evommune Inc (EVMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 12-2024 | 09-2024 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 26,818 | N/A | 0 |
| Marketable Securities | N/A | 49,244 | N/A | 0 |
| TOTAL | $N/A | $81,941 | $N/A | $0 |
| Non-Current Assets | ||||
| PPE Net | N/A | 970 | N/A | N/A |
| Other Non-Current Assets | 0 | 1,633 | 0 | 0 |
| TOTAL | $N/A | $2,603 | $N/A | $N/A |
| Total Assets | $N/A | $84,544 | $N/A | $0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 3,576 | 0 | 0 |
| Accrued Expenses | N/A | 6,309 | N/A | 0 |
| Other current liabilities | N/A | 371 | N/A | 0 |
| TOTAL | $N/A | $10,416 | $N/A | $0 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 257,265 | 0 | 0 |
| TOTAL | $N/A | $257,265 | $N/A | $N/A |
| Total Liabilities | $N/A | $267,681 | $N/A | $0 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 36,018 | 31,524 | N/A | N/A |
| Retained earnings | N/A | -192,816 | N/A | 0 |
| TOTAL | $N/A | $-183,137 | $N/A | $0 |
| Total Liabilities And Equity | $0 | $84,544 | $0 | $0 |